|
Market Closed -
Nasdaq
16:00:00 2026-10-07 EDT
|
5-day change | 1st Jan Change | ||
| 16.42 USD | -6.17% |
|
-9.58% | - |
| 09-20 | Attovia Therapeutics, Inc.(NasdaqGM:ATTO) added to S&P TMI Index | CI |
| 09-16 | Attovia Therapeutics, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-16-2026 10:00 AM |
Chart calendar Attovia Therapeutics, Inc.
Upcoming events on Attovia Therapeutics, Inc.
No events available
Past events on Attovia Therapeutics, Inc.
Annual results
| Fiscal Period | December | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,47 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -90,0 | -120 | -140 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -90,6 | -120 | -141 |
|
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 | 0,00 | 0,00 | 0,00 |
|
Net income Million USD | Released Forecast Spread | -60,9 | -83,4 | -107 | -136 |
|
EPS USD | Released Forecast Spread | -1,66 | -2,78 | -2,10 | -2,44 |
| Announcement Date | 14/07/26 | - |
Quarterly results
| Fiscal Period | June | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,45 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -21,5 | -22,7 | -24,2 | -29,5 | -29,5 | ||
|
EBIT Million USD | Released Forecast Spread | -21,8 -22,1 1.24% | -23,5 | -24,6 | -29,8 | -29,8 | ||
|
Net income Million USD | Released Forecast Spread | -20,7 -19,5 -6.09% | -20,6 | -21,9 | -28,6 | -28,6 | ||
|
EPS USD | Released Forecast Spread | -4,88 -2,82 -73.36% | -0,57 | -0,49 | -0,44 | -0,44 | ||
| Announcement Date | 02/09/26 | - | - | - | - | - | - |
| 2026-10-13 |  | Présentation aux Actionnaires / Analystes | |
| 2026-10-13 | | Information meeting | 16:30 |
| 2026-10-13 | | Extraordinary General Meeting | 22:00 |
| 2026-10-14 | | Information meeting | 14:30 |
| 2026-10-14 | | Présentation aux Actionnaires / Analystes | |
| 2026-10-14 | | Sales and Revenue Release - Q3 2026 | |
| 2026-10-14 | | Information meeting | 08:00 |
| 2026-10-22 | | Earnings release - Q3 2026 | |
| 2026-10-23 | | Extraordinary General Meeting | 02:00 |
| 2026-10-26 | | Présentation aux Actionnaires / Analystes |
Past sector events for Attovia Therapeutics, Inc.
| 2026-10-07 | | Extraordinary General Meeting | 09:00 |
| 2026-10-07 | | Présentation aux Actionnaires / Analystes | 09:00 |
| 2026-10-06 | | Information meeting | 10:00 |
| 2026-10-05 | | Information meeting | 08:00 |
| 2026-10-01 | | Présentation aux Actionnaires / Analystes | 08:00 |
| 2026-09-30 | | Information meeting | 13:00 |
| 2026-09-29 | | Extraordinary General Meeting | 02:00 |
| 2026-09-29 | | Information meeting | 08:00 |
| 2026-09-29 | | Information meeting | 08:30 |
| 2026-09-29 | | Présentation aux Actionnaires / Analystes | 08:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ATTO Stock
- Calendar Attovia Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
